由Informa Pharmaceutical Science出版（原名Ashley Publications）。國際標(biāo)準(zhǔn)書號(hào)：1354-3776。《關(guān)于治療專利的專家意見》（ISSN1354-3776）每月出版一期，是醫(yī)藥專利信息方面的領(lǐng)先專利期刊。關(guān)于治療專利的專家意見提供了一個(gè)每月的，同行評(píng)審的指導(dǎo)，以技術(shù)進(jìn)步和藥物專利的發(fā)展。鼓勵(lì)作者對(duì)所審查研究的現(xiàn)狀發(fā)表專家意見，而不是簡單地審查現(xiàn)有數(shù)據(jù)。該期刊的每一期都包含了注釋性的專利選擇和簡短的專利評(píng)估，突出了相關(guān)專家認(rèn)為具有潛在重要性的發(fā)明和創(chuàng)新理念。觀眾包括制藥行業(yè)的科學(xué)家、管理者和決策者，以及其他與研發(fā)密切相關(guān)的人。訂戶包括美國、歐洲和日本的大多數(shù)主要制藥公司，以及許多生物技術(shù)公司。關(guān)于治療專利的專家意見采用了系統(tǒng)的覆蓋方法，每個(gè)問題都集中在一個(gè)主要的治療領(lǐng)域。

Published by Informa Pharmaceutical Science (formerly Ashley Publications). ISSN: 1354-3776.Expert Opinion on Therapeutic Patents (EOTP) (ISSN 1354-3776) is published monthly and is the leading patent journal for pharmaceutical patent information. Expert Opinion on Therapeutic Patents provides a monthly, peer-reviewed guide to the technological advances and developments in pharmaceutical patents. Authors are encouraged to express their Expert Opinion of the status of the research under review, rather than to simply review the available data. Each issue of the journal contains annotated patent selections and short patent evaluations which highlight inventions and innovative ideas deemed by relevant experts to be of potential importance. The audience consists of scientists, managers and decision-makers in the pharmaceutical industry, and others closely involved in R&D. Subscribers include most of the major pharmaceutical companies in the USA, Europe and Japan, and many biotechnology companies. Expert Opinion on Therapeutic Patents adopts a systematic approach to coverage, with each issue focusing on one of the major therapeutic areas.